Home›Companies›Biotech & Pharma›Basking Biosciences

Basking Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 22, 2025·Suggest an edit

About Basking Biosciences

Basking Biosciences is a private company based in Cary, North Carolina. It has reported $56,901,122 raised in two offerings on Form D since September 2020. Its chief executive is Julia Owens.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 31, 2023Nov 15, 2023amended Oct 22, 2025$55,000,000fully sold11$5.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Aug 28, 2020Sep 10, 2020$1,901,122of $7.0M target6$316KEquityRule 506(b)Form D ↗
Total, two offerings$56,901,122

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Basking Biosciences's Form D filed Oct 22, 2025.

HC
Hannah Chang
Director
JO
Julia Owens
CEO and director
AA
Aiden Aceves
Director
DA
David Adair
Director
SG
Steve Gillis
Director
AN
Ari Nowacek
Director
SN
TN

Earlier filings also listed Ryan Helon (director, last listed Sep 2020), Richard Shea (ceo and director, last listed Sep 2020), Dan Myers (director, last listed Sep 2020) and Bruce Sullenger (director, last listed Sep 2020).

Sources

  1. SECBasking Biosciences, Inc. Form D, filed Nov 15, 2023
  2. SECBasking Biosciences, Inc. filing history